Structure Therapeutics In... (GPCR)
NASDAQ: GPCR
· Real-Time Price · USD
19.80
1.27 (6.85%)
At close: Aug 15, 2025, 1:22 PM
Structure Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -61.66M | -46.83M | -36.52M | -33.98M | -26.03M | -25.99M | -24.67M | -23.86M | -23.28M | -17.98M | -11.88M | -12.42M | -13.95M | -13.08M | -13.36K |
Depreciation & Amortization | 291K | 274K | 273K | 265K | 231.74K | 658.93K | 280.92K | 79K | 74K | 70K | 72K | 76K | 59K | 70K | 66.00 |
Stock-Based Compensation | 7.51M | 5.92M | 5.83M | 6.02M | 4.2M | 2.74M | 2.1M | 1.86M | 1.7M | 2.53M | 623K | 628K | 643K | 620K | 937.00 |
Other Working Capital | 7.49M | -7.49M | -111K | 7.39M | 2.35M | -9.97M | 1.34M | 5.13M | 5.12M | -3.75M | -320K | -846K | 1.61M | 371K | 439.00 |
Other Non-Cash Items | -7.5M | -4.79M | -5.67M | -5.71M | -2.75M | -1.03M | -1.08M | 276K | 88K | -262K | -812K | 93K | 96K | 65K | 65.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.27M | -1.66M | -1.64M | n/a | 410K | -280K | -130K | 6.01K | 4.00 |
Change in Working Capital | 6.8M | -6.8M | -534K | 13.7M | -2.03M | -8.16M | 2.73M | 2.75M | 6.17M | -4.67M | -444K | 1.42M | 3.19M | -1.19M | 1.52K |
Operating Cash Flow | -54.56M | -52.23M | -36.47M | -19.7M | -26.37M | -34.02M | -21.91M | -20.56M | -16.89M | -20.31M | -12.03M | -10.48M | -10.1M | -13.52M | -10.76K |
Capital Expenditures | -232K | -314K | -15.22K | -685K | -427K | -161.74K | -1.16M | -820K | -191K | n/a | -71K | -72K | 53K | -65K | -120 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -37.57K | -30.95K | 68.52K | n/a | -10.41K | 16.59K | 16.13K | n/a | n/a |
Purchase of Investments | -88.83M | -116.11M | -132.25M | -255.18M | -283.21M | -31.87M | -237.01M | -14.93M | 24.26M | -190.1M | -9.19M | -45.98M | -26.63M | -41.65M | n/a |
Sales Maturities Of Investments | 138M | 150.45M | 165.5M | 66.55M | 79.4M | 33.45M | 57.28M | 45.88M | -92.78M | 141.08M | 19.6M | 29.4M | 10.5M | 2M | 1.2K |
Other Investing Acitivies | n/a | n/a | n/a | 275.07K | -275K | 1.58K | n/a | 30.95K | -68.52K | -49.02K | 10.41K | -16.59K | -16.13K | -39.65K | 1.2K |
Investing Cash Flow | 48.94M | 34.03M | 33.23M | -189.04M | -204.51M | 1.42M | -180.89M | 30.13M | -68.71M | -49.02M | 10.34M | -16.66M | -16.07M | -39.72M | 1.08K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.99K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 517K | 809K | 615K | -757K | -588K | 702K | -18.37M | 473K | -297K | -2.57M | -316K | -259K | 31.04M | -1.45M | -115K |
Financial Cash Flow | 517K | 809K | 615K | -757K | 514.01M | 700.86K | 281.97M | 473K | -297K | 169.73M | -316K | -259K | 31.04M | -1.45M | -115 |
Net Cash Flow | n/a | -17.39M | -2.62M | -209.5M | 283.81M | -31.96M | 79.16M | 10.04M | -85.9M | 100.4M | -2M | -27.4M | 4.87M | -54.68M | -9.79K |
Free Cash Flow | -54.79M | -52.54M | -36.48M | -20.38M | -26.82M | -34.19M | -23.07M | -21.38M | -17.09M | -20.31M | -12.1M | -10.55M | -10.04M | -13.58M | -10.88K |